Innoviva, Inc.
INVA
$21.46
$0.020.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 80.82% | 63.34% | 61.38% | 52.96% | 81.56% |
| Total Other Revenue | 0.30% | 1.21% | 9.59% | 4.04% | -13.66% |
| Total Revenue | 18.70% | 15.54% | 21.46% | 13.80% | -1.91% |
| Cost of Revenue | -34.07% | -49.64% | -4.15% | -10.34% | 23.45% |
| Gross Profit | 37.01% | 44.38% | 29.60% | 22.22% | -8.44% |
| SG&A Expenses | 3.56% | 17.77% | 31.66% | 35.87% | 52.35% |
| Depreciation & Amortization | 6.22% | 18.90% | 33.90% | 80.57% | 160.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.84% | -2.82% | -0.36% | 4.05% | 28.14% |
| Operating Income | 48.01% | 43.95% | 55.66% | 28.10% | -27.44% |
| Income Before Tax | -123.39% | -80.74% | 8.34% | -43.06% | -30.10% |
| Income Tax Expenses | -19.73% | -2.64% | -49.25% | -89.41% | -74.75% |
| Earnings from Continuing Operations | -132.93% | -86.98% | 29.50% | -26.25% | -16.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -132.93% | -86.98% | 29.50% | -37.68% | -22.15% |
| EBIT | 48.01% | 43.95% | 55.66% | 28.10% | -27.44% |
| EBITDA | 41.11% | 40.14% | 52.46% | 33.93% | -17.68% |
| EPS Basic | -133.73% | -86.70% | 23.55% | -32.98% | -15.74% |
| Normalized Basic EPS | 58.76% | 55.18% | 72.92% | -6.39% | -31.98% |
| EPS Diluted | -144.74% | -90.46% | 55.69% | -26.90% | -1.23% |
| Normalized Diluted EPS | 84.31% | 69.91% | 71.95% | -5.23% | -35.59% |
| Average Basic Shares Outstanding | -2.63% | -4.16% | -5.88% | -6.66% | -7.09% |
| Average Diluted Shares Outstanding | -15.19% | -9.87% | -5.17% | -0.79% | -1.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |